Avandia
Avandia Side Effects May Lead To Heart Attack Lawsuits
Avandia Side Effects Risk Of Heart Attack. Avandia, a drug used to treat type 2 diabetes, has been linked to a significant risk of heart attack, strokes and heart failure. In 2010, the US Food & Drug Administration (FDA) severely restricted sales of Avandia. Avandia has also been restricted in Canada, and Avandia sales … [Read more...] about Avandia Side Effects May Lead To Heart Attack Lawsuits
Avandia Side Effects Have Been Linked To Heart Attacks Lawsuits
Avandia Side Effects. In September 2010, the Food Drug Administration (FDA) placed severe restrictions on Avandia, citing its heart risks. The FDA's directive means that patients in the US will only have access to Avandia if they and their doctors attest that they have tried every other diabetes medicine and that patients … [Read more...] about Avandia Side Effects Have Been Linked To Heart Attacks Lawsuits
FDA on Avandia Restrictions
Health Officials Consider Avandia Restrictions. The knell appeared to sound for Avandia a few years ago when federal health officials decided to almost ban the drug outright because it had been linked to myriad health problems. Today, the U.S. Food and Drug Administration (FDA) is appearing to go back on those restrictions as the … [Read more...] about FDA on Avandia Restrictions
Avandia Heart Attack Lawsuits Settlements
Avandia Heart Attack Lawsuits. GlaxoSmithKline has reportedly agreed to settle more than 20,000 Avandia heart attack lawsuits, according to a report from Bloomberg News. The agreement to settle the Avandia lawsuits was reached in court-ordered mediation and comes just months after Glaxo said it would pay $3 billion to settle U.S. … [Read more...] about Avandia Heart Attack Lawsuits Settlements
Avandia Curbs
Avandia Curbs Will be in Effect. The U.S. Food & Drug Administration (FDA) has finally announced how and when it will implement new restrictions for Avandia and other diabetes drugs containing rosiglitazone. Because of the new restrictions, Avandia will no longer be available at retail pharmacies after November … [Read more...] about Avandia Curbs
1,000 Avandia Settlements
1,000 Avandia Settlements. Momentum appears to be building towards more Avandia lawsuit settlements. Bloomberg News is reporting that GlaxoSmithKline, maker of the controversial diabetes drug, is close to resolving about 1,000 Avandia lawsuits now pending in state courts. During a hearing in the Philadelphia federal court where … [Read more...] about 1,000 Avandia Settlements
Avandia Black Box Warning Wasn’t Heeded by All Doctors
Avandia Black Box Warning. Not all doctors are heeding warnings for Avandia. According to a study published in The New England Journal of Medicine that used Avandia as an example, model sort vary across the country in response to warnings about medications from the US Food & Drug Administration (FDA). Earlier this … [Read more...] about Avandia Black Box Warning Wasn’t Heeded by All Doctors
Avandia Bisphosphonate Weaknesses Problems
Avandia, Bisphosphonate Problems. Recent safety issues involving the diabetes drug Avandia and a class of bone drugs called bisphosphonates have some questioning the way drugs are approved for sale in the US. According to a recent New York Times’ news analysis, problems that have cropped up with Avandia, bisphosphonates and other … [Read more...] about Avandia Bisphosphonate Weaknesses Problems
GlaxoSmithKline Outlook Falls
GlaxoSmithKline Outlook Falls. GlaxoSmithKline’s Avandia problems are expected to take a toll on the drug maker’s bottom line. According to a Reuters report, analysts have already begun cutting Glaxo’s earnings forecast, after regulators in the US and Europe announced separate actions that will likely scuttle Avandia’s … [Read more...] about GlaxoSmithKline Outlook Falls
Avandia Disclosures Prompt FDA Probe
Data On Avandia Heart Risks. Avandia may be about to cause more trouble for GlaxoSmithKline. According to a report in TIME Magazine, the US Food & Drug Administration (FDA) is trying to determine if Glaxo broke the law when it didn’t disclose data on the controversial diabetes drug’s heart risks. Since November 2007, Avandia’s … [Read more...] about Avandia Disclosures Prompt FDA Probe
Avandia Decision Coming in September
Avandia Decision Coming in September. European regulators will decide by September if Avandia will be allowed to stay on the market there. The European Medicines Agency (EMEA) said yesterday that it is still reviewing GlaxoSmithKline’s controversial diabetes drug, which has been linked to an increased risk of heart attacks. Since … [Read more...] about Avandia Decision Coming in September
Findings of Avandia Study Kept Under Wraps
Findings of Avandia Study Kept Under Wraps by Drug Maker. The maker of Avandia had evidence about the drug’s heart risks as early as 1999, but concealed that information from U.S. regulators and the public. According to a new report in The New York Times, SmithKline Beecham, now GlaxoSmithKline, began a study that year to … [Read more...] about Findings of Avandia Study Kept Under Wraps
FDA Staff Cite Avandia Concerns
FDA Staff Cite Avandia Concerns. Avandia continues to raise safety concerns with staff at the Food & Drug Administration (FDA), according to a 756-page briefing posted on the agency’s Website. The documents were posted in advance of an advisory panel meeting next week that could help determine whether or not Avandia, known … [Read more...] about FDA Staff Cite Avandia Concerns
Avandia Decision Looms for FDA
FDA Will Discuss The Safety Of Avandia. In two weeks, a U.S. Food & Drug Administration (FDA) advisory panel will meet to discuss the safety of the controversial diabetes drug, Avandia. In the past, the Avandia issue has sharply divided the agency. However, over the past several years, concerns about Avandia side effects have … [Read more...] about Avandia Decision Looms for FDA
German Drug Regulator Rejected Avandia
A German regulator has rejected Avandia, directing health insurers in that country to stop paying for GlaxoSmithKline’s controversial diabetes drug. The decision comes just a month before a U.S. Food & Drug Administration (FDA) advisory panel meeting is held on Avandia. commission commission The ban on glitazone medicines … [Read more...] about German Drug Regulator Rejected Avandia
Avandia Heart Attack Risk
Avandia May Cause Heart Attacks And Stroke. An unpublished Avandia study has found that patients in the U .S. Medicare system who took the drug may have suffered as many as 48,000 heart attacks, strokes and other problems between 1999 and 2009. According to the study’s author, Dr. David Graham, a safety official with the … [Read more...] about Avandia Heart Attack Risk
Avandia Lawsuits Settlement
GlaxoSmithKline Settles Avandia. Thousands of Avandia lawsuits that were scheduled to come to trial in a state court in Philadelphia, PA this month have been settled. According to a Reuters report, half of the estimated 13,000 Avandia lawsuits filed against GlaxoSmithKline have now been settled. There were around 5,000 … [Read more...] about Avandia Lawsuits Settlement
Avandia Study Has Few Takers
Controversial Avandia Safety Concerns. A much maligned Avandia trial is having problems recruiting participants, according to The Wall Street Journal. The study, called TIDE, has already faced criticism from some medical ethicists, and as we have reported previously, there is speculation that the U.S. Food & Drug … [Read more...] about Avandia Study Has Few Takers
Glaxo Settled 700 Avandia Lawsuits
Glaxo Settled Avandia Lawsuits. GlaxoSmithKline has reportedly settled around 700 Avandia lawsuits. According to a Bloomberg report, the drug maker has agreed to pay out $60 million to people who claimed the controversial diabetes drug caused them to suffer a heart attack or stroke. While more than 4,000 Avandia lawsuits already … [Read more...] about Glaxo Settled 700 Avandia Lawsuits
Avandia Most Adverse Event Report
Avandia, Seroquel Adverse Events. Avandia’s cardiovascular problems have long been the subject of concern and controversy. Now, reports FiercePharma, an adverse event (AE) report for last year’s third quarter indicated that GlaxoSmithKline’s Avandia (generic: rosiglitazone) was number one on the list. The Institute for Safe … [Read more...] about Avandia Most Adverse Event Report
Avandia Lawsuit Charges Glaxo with False Advertising
Avandia Lawsuit Over False Advertising. California's Santa Clara County has filed suit against GlaxoSmithKline over Avandia. According to the MercuryNews.com, Santa Clara County’s lawsuit is the first governmental lawsuit claiming the drug maker falsely advertised Avandia’s benefits and concealed its risks. The Avandia … [Read more...] about Avandia Lawsuit Charges Glaxo with False Advertising
Senate Avandia Report Flawed
Avandia Potential Heart Risks. GlaxoSmithKline has released a 30-page "white paper", defending itself from charges that it downplayed Avandia's potential heart risks. The white paper followed release of a Senate Finance Committee report that was highly critical of both Glaxo and the U.S. Food & Drug Administration (FDA) … [Read more...] about Senate Avandia Report Flawed
Women Face Fracture Risk from Avandia
Fracture Risk From Thiazolidinediones. Another study has linked thiazolidinediones, a class of diabetes drugs which include Avandia and Actos, with a higher risk of bone fractures, specifically in women. This study was conducted by the Center for Health Services Research at Henry Ford Hospital and published in the February … [Read more...] about Women Face Fracture Risk from Avandia
Glaxo Documents in Avandia Lawsuit Not Covered by Attorney-Client Privilege
Documents in Avandia Lawsuit. GlaxoSmithKline's claims of attorney-client privilege have been rejected in an Avandia lawsuit. On December 9, a federal judge ordered the drugmaker to produce dozens of Avandia documents it was trying to withhold. The ruling on the Avandia documents was made by the Honorable Cynthia M. … [Read more...] about Glaxo Documents in Avandia Lawsuit Not Covered by Attorney-Client Privilege
Avandia Riskier for Elderly
Avandia Riskier for Elderly. The diabetes drug Avandia carries more risk than Actos, a new study conducted by Canadian researchers has found. According to a Reuters report, seniors in the study taking Avandia were more likely to suffer from heart failure, and were more likely to die. The findings prompted the authors of the … [Read more...] about Avandia Riskier for Elderly
Group Says Avandia Ups Risk For Liver Damage
Avandia Ups Risk For Liver Damage. According to emerging research, GlaxoSmithKline’s diabetes drug, Avandia, can cause death as a result of liver failure, and should be banned by the U.S. Food & Drug Administration (FDA). The group, Public Citizen, published the research in the peer-reviewed medical journal … [Read more...] about Group Says Avandia Ups Risk For Liver Damage
Avandia Linked Increased Death Risk
Avandia Increase Risk Of Cardiovascular Events. According to a study published in a recent issue of the Archives of Internal Medicine, the diabetes drug rosiglitazone maleate—also known as Avandia—may increase the risk of certain cardiovascular events. The study, which was conducted by Dr. Wolfgang Winkelmayer of Brigham and … [Read more...] about Avandia Linked Increased Death Risk
Avandia Disappoints Again
Avandia Does Not Reduce Arterial Plaque. Avandia, GlaxoSmithKline's controversial diabetes drug, does not reduce arterial plaque buildup in any significant way, according to a new study. This news only adds to the uncertainty surrounding Avandia, which has been the subject of safety worries since it was tied to an increased risk of … [Read more...] about Avandia Disappoints Again
Avandia Liver Failure Prompts Ban
Avandia Liver Failure Reports. Avandia has been linked to more than a dozen cases of liver failure, most of which proved fatal. Reports of liver failure and deaths linked to ‘Avandia’ have prompted the consumer group Public Citizen to file a petition with the Food & Drug Administration (FDA) asking that the diabetes drug be … [Read more...] about Avandia Liver Failure Prompts Ban
Patients Sue Glaxo Have Suppressed Data on Avandia
Glaxo Drug May Cause Heart Attacks. Two North Carolina patients have sued GlaxoSmithKline claiming its diabetes drug, Avandia, caused their heart attacks. Hundreds more are seeking compensation for health problems they experienced after taking Avandia. The patients blame Glaxo for not adequately warning of all of the pill's … [Read more...] about Patients Sue Glaxo Have Suppressed Data on Avandia
FDA Rebukes Glaxo for Avandia Study
The US Food and Drug Administration Federal (FDA) has just issued a warning to the drug maker, GlaxoSmithKline, for not reporting safety results on its diabetes pill Avandia. Avandia received the prominent, “Black Box” warning label last year and the FDA said that between 2001 and 2007 GlaxoSmithKline neglected to update the agency … [Read more...] about FDA Rebukes Glaxo for Avandia Study
GlaxoSmithKline, AstraZeneca Under Iraq Bribe Probe
AstraZeneca at Center of Iraq. GlaxoSmthKline, the maker of Avandia, and AstraZeneca, another large drug maker, are being investigated in Britain for allegedly bribing the regime of Saddam Hussein in Iraq. The revelation of the UK bribe probe is bad news for both companies, but it especially ominous for Glaxo. Glaxo has … [Read more...] about GlaxoSmithKline, AstraZeneca Under Iraq Bribe Probe
HealthTrans Pharmacy Removed Avandia
Avandia Removed from HealthTrans Pharmacy. Avandia has taken another hit on the chin, as two large pharmacy benefit managers announced that they would be dropping the controversial diabetes drug from their value-based prescription drug formularies as of January 1, 2008 because of safety concerns. The decision by … [Read more...] about HealthTrans Pharmacy Removed Avandia
Avandia Heart Attack Controversy
Avandia Heart Attack Controversy, Avandia, a drug used in the treatment of type 2 diabetes, has been at the center of controversy since being linked to an increased risk of heart attack last May. An update to the black box warning-today's strongest drug warning-is now being added to the Avandia label. the U.S. Food and Drug … [Read more...] about Avandia Heart Attack Controversy
Avandia Controversy Won’t Go Away with New Black Box Warning
Avandia Heart Attack Black Box Warning. Avandia is getting yet another break from the Food & Drug Administration (FDA). While the FDA did announce the addition of a long-awaited black box warning for Avandia’s increased risk of heart attacks, it is not the strongly worded warning that many patient advocates had call … [Read more...] about Avandia Controversy Won’t Go Away with New Black Box Warning
Avandia Vote at FDA Kept Secret
Avandia Vote at FDA Kept Secret. Avandia may have been the subject of a secret vote by a Food & Drug Administration (FDA) panel in which it apparently decided by a one-vote margin to keep the controversial drug on the market. Now, a member of the US Senate wants to know if the report of the 8-7 vote by the FDA’s Drug … [Read more...] about Avandia Vote at FDA Kept Secret
Avandia Heart Attack Risk Warning
Avandia Black Box Warning. An Avandia black box warning about its potential to cause heart attacks could soon appear on the drug’s label if officials at the Food & Drug Administration (FDA) have their way. The FDA is said to be pushing hard for the black box warning, the FDA’s strictest, to be including on Avandia’s … [Read more...] about Avandia Heart Attack Risk Warning
Avandia Blasted as GlaxoSmithKline Takes Another Blow to the Chin
Avandia May Cause Complications. Avandia has come under fire again after a German study found that the controversial diabetes medication did little to improve quality of life for patients using it. In fact, the analysis found that Avandia could actually worsen complications of the disease. The new study was conducted at … [Read more...] about Avandia Blasted as GlaxoSmithKline Takes Another Blow to the Chin
Drug Companies & Continuing Medical Education
Drug Companies Bribing Doctors To Prescribe Drugs. A report released last month by the Senate Finance Committee revealed a dirty little secret about pharmaceutical marketing. Drug companies are bribing doctors to prescribe certain medications. But pharmaceutical companies are not exactly slipping physicians envelopes … [Read more...] about Drug Companies & Continuing Medical Education
Avandia Boosts Heart Attack Risk
A widely prescribed drug to treat Type 2 diabetes substantially increases the risk of heart attacks and death from cardiovascular disease, according to a study released today that critics say questions the government's ability to monitor drug safety. Patients who took Avandia to reduce their blood sugar levels were 43% more likely … [Read more...] about Avandia Boosts Heart Attack Risk
FDA Diabetes Drug Safety Alert
Diabetes Drug Avandia Linked To Heart Attacks. The widely prescribed diabetes drug Avandia is linked to a greater risk of heart attack and possibly death, a new scientific analysis revealed, and the U.S. government issued a safety alert Monday. The Food and Drug Administration urged diabetics taking the pill to talk to their … [Read more...] about FDA Diabetes Drug Safety Alert
Diabetics Warned About Taking St. John’s Wort
Warned About Taking St. John’s Wort. Diabetics who are taking rosiglitazone (Avandia), which is one of a new generation of treatments for type 2 diabetes, should not also take St. John's wort, reveals a new study presented at the annual meeting of the American Society of Pharmacology and Therapeutics in Orlando, … [Read more...] about Diabetics Warned About Taking St. John’s Wort
